Radiological findings in non-surgical recurrent hepatocellular carcinoma:From locoregional treatments to immunotherapy  

作　　者：Davide Ippolito Cesare Maino Marco Gatti Paolo Marra Riccardo Faletti Francesco Cortese Riccardo Inchingolo Sandro Sironi 

机构地区：[1]Department of Radiology,IRCCS San Gerardo dei Tintori,Monza 20900,Italy [2]School of Medicine and Surgery,University of Milano-Bicocca,Milano 20121,Italy [3]Department of Surgical Sciences,University of Turin,Turin 10126,Italy [4]Department of Diagnostic and Interventional Radiology,Papa Giovanni ⅩⅩⅢ Hospital,Bergamo 24127,Italy [5]Interventional Radiology Unit,“F.Miulli”Regional General Hospital,Bari 70121,Italy

出　　处：《World Journal of Gastroenterology》2023年第11期1669-1684,共16页世界胃肠病学杂志（英文版）

摘　　要：Since hepatocellular carcinoma(HCC)represents an important cause of mortality and morbidity all over the world.Currently,it is fundamental not only to achieve a curative treatment but also to manage in the best way any possible recurrence.Even if the latest update of the Barcelona Clinic Liver Cancer guidelines for HCC treatment has introduced new locoregional techniques and confirmed others as well-established clinical practices,there is still no consensus about the treatment of recurrent HCC(RHCC).Locoregional treatments and medical therapy represent two of the most widely accepted approaches for disease control,especially in the advanced stage of liver disease.Different medical treatments are now approved,and others are under investigation.On this basis,radiology plays a central role in the diagnosis of RHCC and the assessment of response to locoregional treatments and medical therapy for RHCC.This review summarized the actual clinical practice by underlining the importance of the radiological approach both in the diagnosis and treatment of RHCC.

关 键 词：Carcinoma HEPATOCELLULAR Liver Ablation CATHETER Radio frequency ablation Ablation techniques Medication therapy management RECIST 

分 类 号：R735.7[医药卫生—肿瘤]